查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908231

基因组编辑市场规模、份额和趋势分析报告：按技术、交付方式、应用、模式、最终用途、地区和细分市场预测（2026-2033 年）

Genome Editing Market Size, Share & Trends Analysis Report By Technology, By Delivery Method, By Application, By Mode, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

基因组编辑市场概览

全球基因组编辑市场预计到 2025 年将价值 113.7 亿美元，预计到 2033 年将达到 398.1 亿美元。

预计从 2026 年到 2033 年，该产业将以 17.03% 的复合年增长率成长。这一增长可归因于临床前模型的成功推动了对基因组编辑疗法的需求，市场参与企业之间为业务发展而日益激烈的竞争，基因编辑技术的进步，以及农业生物技术领域的日益普及。

新冠感染疾病对市场造成了重大衝击，扰乱了包括临床试验中断、供应链挑战和严格监管在内的许多方面。封锁措施、旅行限制和劳动力减少也对生产和供应链造成了影响，导致基因治疗产品的生产和分销延误。儘管面临这些挑战，基因组编辑行业的公司已透过实施适应性策略来适应新常态，并有望从新冠疫情的影响中恢復过来。疫情加速了基因修饰技术的研究和开发活动，尤其是在迫切需要有效的新冠病毒治疗方法和疫苗的情况下。例如，南洋理工大学的研究人员于2021年3月开发了VaNGuard（变异核苷酸卫士）诊断测试，该测试能够检测出带有突变的SARS-CoV-2株。这项进展可望加速CRISPR基因组编辑技术的应用。

基于CRISPR技术的工具的快速发展显着推动了基因组编辑产业的扩张。创新基因组编辑工具的出现，使得基因组DNA的操作更加便捷，为治疗方法研发和疾病检测开闢了新的途径，进而推动了罕见疾病基因组编辑产业的成长。因此，服务供应商拥有进入这一先前尚未开发的领域的盈利机会。此外，政府投入的增加、基因改造作物产量的扩大以及基因组计划的增多，预计也将进一步促进市场成长。

许多公司已与技术开发商签订授权协议以增强其市场地位，而主要企业则透过收购和合作等策略倡议扩大其全球企业发展。例如，2024年2月，Precision BioSciences授予Caribou Biosciences一项非独家全球许可，允许其使用Precision BioSciences的专利技术，该技术可将外源抗原结合受体靶向插入人类T细胞的TRAC基因座。该协议包括预付款、产品销售分成以及潜在的里程碑付款。

基因编辑技术CRISPR是生物技术领域一项快速发展的技术。 CRISPR利用细菌的免疫系统来敲除基因或插入新的基因。传统的基因组编辑方法速度慢、效率低、劳力密集，无法适应基因组改造的快速发展时代。此外，这项技术正在各个领域带来变革性成果，包括植物、动物和细胞株的基因工程，以及药物研发和监测，从而推动市场成长。此技术具有探索不同基因组合、调控基因表现以及阐明单一DNA碱基作用的潜力。

基因组学及相关技术的进步对作物遗传学产生了重大影响。如今，对许多作物物种的基因组和转录组进行定序已成为可能。基因工程工具在农业领域的主要优势包括开发具有各种先进性状（例如提高产量）的基因改造植物和作物。它们还有助于保护生物多样性、减少农业对环境的影响、缓解气候变迁以及减轻贫困和饥饿。

目录

第一章调查方法和范围

第二章执行摘要

第三章 基因组编辑市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 基因组编辑市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析
    • 新冠疫情影响分析

第四章 基因组编辑市场：依技术、估算与趋势分析

  • 依技术分析全球基因组编辑市场波动状况
  • 全球基因组编辑市场规模及趋势分析（依技术划分，2021-2033 年）
  • （CRISPR）/Cas9
  • TALENs/MegaTALs
  • ZFN
  • Meganucleases
  • 其他的

第五章 基因组编辑市场：以交付方式分類的估算与趋势分析

  • 以交付方式分析全球基因组编辑市场的变化
  • 全球基因组编辑市场规模及趋势分析（依交付方式划分，2021-2033 年）
  • 体外
  • 体内

第六章 基因组编辑市场：按应用分類的估算与趋势分析

  • 全球基因组编辑市场按应用领域分類的波动分析
  • 全球基因组编辑市场规模及趋势分析（按应用领域划分，2021-2033 年）
  • 基因工程
    • 细胞株工程
    • 动物基因工程
    • 植物基因工程
    • 其他的
  • 临床应用
    • 诊断药物研发
    • 治疗方法研发

第七章 基因组编辑市场：依模式分類的估算与趋势分析

  • 全球基因组编辑市场模式差异分析
  • 全球基因组编辑市场规模及趋势分析（依模式划分，2021-2033 年）
  • 合约
  • 内部

第八章：基因组编辑市场：依最终用途分類的估算与趋势分析

  • 全球基因组编辑市场最终用途差异分析
  • 全球基因组编辑市场规模及趋势分析（依最终用途划分，2021-2033 年）
  • 生物技术和製药公司
  • 学术和政府研究机构
  • 受託研究机构

第九章 基因组编辑市场：区域、预测与趋势分析

  • 区域市场占有率分析（2025 年和 2033 年）
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2025年商业市场分析
  • 公司简介/列表
    • Merck KGaA
    • Takara Bio Inc.
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript
    • New England Biolabs
    • Charles River Laboratories
    • Eurofins Scientific
    • Lonza
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-1-68038-399-7

Genome Editing Market Summary

The global genome editing market size was estimated at USD 11.37 billion in 2025 and is projected to reach USD 39.81 billion by 2033, growing at a CAGR of 17.03% from 2026 to 2033. This growth can be attributed to the success in preclinical models driving the demand for genome editing therapeutics, rising competition among market participants for business development, technological advancements in gene editing technologies, and increasing adoption in agricultural biotechnology.

The COVID-19 pandemic had a significant impact on the market, causing disruptions in several aspects of the market including clinical trial disruptions, supply chain challenges, and stringent regulations. Manufacturing & supply chains were also affected by lockdown measures, travel restrictions, and reduced workforce, leading to delays in the production & distribution of gene therapy products. Despite these challenges, companies in the genome editing industry have adjusted to the new normal by implementing adaptive measures and are expected to recover from the impact of COVID-19. The pandemic accelerated R&D activities in gene alteration technologies, specifically in response to the urgent need for effective treatments and vaccines for COVID-19. For example, researchers at Nanyang Technological University developed the VaNGuard (Variant Nucleotide Guard) diagnostic test in March 2021, which has the capability to detect SARS-CoV-2 strains with mutations. This advancement is anticipated to leverage the utilization of CRISPR genome editing technology.

The rapid evolution of CRISPR-based tools has significantly led to the expansion of the genome editing industry. The emergence of innovative genome editing tools, which allow easier manipulation of genomic DNA, has brought in a new phase in therapeutic development and disease detection, which derives the growth in rare disease genome editing industry. Consequently, service providers now have a profitable opportunity to tap previously unexplored areas in this field. Moreover, increasing government funding, growing production of genetically modified crops, and a rising number of genomics projects are expected to drive market growth.

Many companies are entering into licensing agreements with technology developers to strengthen their market presence, while key players are engaged in strategic initiatives like acquisitions and partnerships to expand their global presence. For instance, in February 2024, Precision BioSciences granted Caribou Biosciences a non-exclusive, global license to use its patented technology for targeted insertion of exogenous antigen binding receptors into the TRAC gene locus of human T cells. This agreement includes upfront payment, royalties on product sales, and potential milestone payments.

Gene editing technology CRISPR is projected to be the burgeoning technology in biotechnology. CRISPR harnesses the bacterial immune system to either knock genes out or insert new genes. Due to their time-consuming, ineffective, and labor-intensive nature, traditional genome editing methods are only partially capable of keeping pace with the rapidly evolving genome modification era. In addition, technology also provides transformative results in various fields, such as plant, animal, & cell line genetic engineering and drug development & monitoring, which results in growth of the market. Technology has the potential to investigate different gene combinations, control gene expression, and find the role of individual DNA bases.

Advancements in genomics and related technologies have significantly impacted crop genetics. Genomes and transcriptomes can now be sequenced for many crops. Major benefits of gene manipulation tools in agricultural sectors include the development of Genetically Modified (GM) plants/crops with various advanced features, such as increased crop productivity. They also help conserve biodiversity, reduce agricultural eco-footprint, mitigate climate change, and aid in alleviating poverty and hunger.

Global Genome Editing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global genome editing market report based on technology, delivery method, application, mode, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • (CRISPR)/Cas9
  • TALENs/MegaTALs
  • ZFN
  • Meganucleases
  • Others
  • Delivery Method Outlook (Revenue, USD Million, 2021 - 2033)
  • Ex-vivo
  • In-vivo
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Genetic Engineering
    • Cell line engineering
    • Animal genetic engineering
    • Plant genetic engineering
    • Others
  • Clinical Applications
    • Diagnostics Development
    • Therapy Development
  • Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Contract
  • In-house
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biotechnology and pharmaceutical companies
  • Academic and government research institutes
  • Contract research organizations
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Delivery Method Segment
    • 1.2.3. Application Segment
    • 1.2.4. Mode Segment
    • 1.2.5. End Use Segment
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Genome Editing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Success in pre-clinical models drives demand for genome editing therapeutics
      • 3.2.1.2. Rising competition amongst market participants for business development
      • 3.2.1.3. Easy editing solutions for the development of therapeutics for a broad range of diseases
      • 3.2.1.4. Increasing demand for synthetic genes and genetically modified organisms
      • 3.2.1.5. Technological advancements in gene editing technologies
      • 3.2.1.6. Rising adoption in agricultural biotechnology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges concerning clinical translation
      • 3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
      • 3.2.2.3. Off-target effects of CRISPR technology
  • 3.3. Genome Editing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Genome Editing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Genome Editing Market Technology Movement Analysis
  • 4.3. Global Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 4.4. (CRISPR)/Cas9
    • 4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. TALENs/MegaTALs
    • 4.5.1. TALENs/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. ZFN
    • 4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Meganuclease
    • 4.7.1. Meganuclease market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Genome Editing Market: Delivery Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Genome Editing Market Delivery Method Movement Analysis
  • 5.3. Global Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
  • 5.4. Ex Vivo
    • 5.4.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. In-Vivo
    • 5.5.1. In-vivo market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Genome Editing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Genome Editing Market Application Movement Analysis
  • 6.3. Global Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Genetic Engineering
    • 6.4.1. Genetic Engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Cell Line Engineering
      • 6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Animal Genetic Engineering
      • 6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Plant Genetic Engineering
      • 6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Clinical Applications
    • 6.5.1. Clinical applications market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Diagnostics Development
      • 6.5.2.1. Diagnostics development market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Therapy Development
      • 6.5.3.1. Therapy development market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Genome Editing Market: Mode Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Genome Editing Market Mode Movement Analysis
  • 7.3. Global Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
  • 7.4. Contract
    • 7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. In-house
    • 7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Genome Editing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Genome Editing Market End-Use Movement Analysis
  • 8.3. Global Genome Editing Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
  • 8.4. Biotechnology and pharmaceutical companies
    • 8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Academic and government research institutes
    • 8.5.1. Academic and government research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Contract research organizations
    • 8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Genome Editing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2025 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 9.4. North America
    • 9.4.1. U.S.
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework
      • 9.4.1.3. Target disease prevalence
      • 9.4.1.4. Competitive scenario
      • 9.4.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.2. Canada
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Target disease prevalence
      • 9.4.2.4. Competitive scenario
      • 9.4.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.3. Mexico
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Target disease prevalence
      • 9.4.3.4. Competitive scenario
      • 9.4.3.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5. Europe
    • 9.5.1. UK
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework
      • 9.5.1.3. Target disease prevalence
      • 9.5.1.4. Competitive scenario
      • 9.5.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.2. Germany
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Target disease prevalence
      • 9.5.2.4. Competitive scenario
      • 9.5.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.3. France
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Target disease prevalence
      • 9.5.3.4. Competitive scenario
      • 9.5.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.4. Italy
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Target disease prevalence
      • 9.5.4.4. Competitive scenario
      • 9.5.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.5. Spain
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Target disease prevalence
      • 9.5.5.4. Competitive scenario
      • 9.5.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.6. Norway
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Target disease prevalence
      • 9.5.6.4. Competitive scenario
      • 9.5.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.7. Sweden
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Target disease prevalence
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Competitive scenario
      • 9.5.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Target disease prevalence
      • 9.5.8.4. Competitive scenario
      • 9.5.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Japan
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework
      • 9.6.1.3. Target disease prevalence
      • 9.6.1.4. Competitive scenario
      • 9.6.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.2. China
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Target disease prevalence
      • 9.6.2.4. Competitive scenario
      • 9.6.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.3. India
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.4. Australia
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Target disease prevalence
      • 9.6.4.4. Competitive scenario
      • 9.6.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Target disease prevalence
      • 9.6.5.4. Competitive scenario
      • 9.6.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.6. Thailand
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Target disease prevalence
      • 9.6.6.3. Regulatory framework
      • 9.6.6.4. Competitive scenario
      • 9.6.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Brazil
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework
      • 9.7.1.3. Target disease prevalence
      • 9.7.1.4. Competitive scenario
      • 9.7.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.2. Argentina
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Target disease prevalence
      • 9.7.2.4. Competitive scenario
      • 9.7.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.8. MEA
    • 9.8.1. South Africa
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Target disease prevalence
      • 9.8.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.8.2. Saudi Arabia
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Target disease prevalence
      • 9.8.2.4. Competitive scenario
      • 9.8.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.8.3. UAE
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Target disease prevalence
      • 9.8.3.4. Competitive scenario
      • 9.8.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.8.4. Kuwait
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Target disease prevalence
      • 9.8.4.4. Competitive scenario
      • 9.8.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2025
  • 10.4. Company Profiles/Listing
    • 10.4.1. Merck KGaA
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Takara Bio Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Revvity, Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Danaher Corporation
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. GenScript
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. New England Biolabs
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Charles River Laboratories
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Eurofins Scientific
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Lonza
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Thermo Fisher Scientific, Inc.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global genome editing market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 4 Global genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 5 Global genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 7 Global genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 8 Global genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 9 Global genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 10 North America genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 11 North America genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 12 North America genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 13 North America genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 14 North America genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 15 North America genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 16 North America genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 17 North America genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 18 U.S. genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 19 U.S. genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 20 U.S. genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 21 U.S. genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 22 U.S. genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 23 U.S. genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 24 U.S. genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Canada genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 26 Canada genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 27 Canada genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 28 Canada genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 29 Canada genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 30 Canada genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 31 Canada genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Mexico genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 33 Mexico genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 34 Mexico genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 35 Mexico genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 36 Mexico genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 37 Mexico genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 38 Mexico genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Europe genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 40 Europe genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 41 Europe genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 42 Europe genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 43 Europe genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 44 Europe genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 45 Europe genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 46 Europe genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Germany genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 48 Germany genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 49 Germany genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 50 Germany genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 51 Germany genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 52 Germany genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 53 Germany genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 54 UK genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 55 UK genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 56 UK genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 57 UK genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 58 UK genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 59 UK genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 60 UK genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 61 France genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 62 France genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 63 France genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 64 France genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 65 France genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 66 France genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 67 France genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 68 Italy genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 69 Italy genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 70 Italy genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 71 Italy genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 72 Italy genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 73 Italy genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 74 Italy genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Spain genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 76 Spain genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 77 Spain genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 78 Spain genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 79 Spain genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 80 Spain genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 81 Spain genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Denmark genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 83 Denmark genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 84 Denmark genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 85 Denmark genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 86 Denmark genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 87 Denmark genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 88 Denmark genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Sweden genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 90 Sweden genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 91 Sweden genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 92 Sweden genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 93 Sweden genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 94 Sweden genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 95 Sweden genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Norway genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 97 Norway genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 98 Norway genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 99 Norway genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 100 Norway genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 101 Norway genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 102 Norway genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 103 Asia Pacific genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 104 Asia Pacific genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 105 Asia Pacific genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 106 Asia Pacific genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 107 Asia Pacific genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 108 Asia Pacific genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 109 Asia Pacific genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 110 Asia Pacific genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 111 China genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 112 China genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 113 China genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 114 China genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 115 China genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 116 China genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 117 China genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 118 Japan genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 119 Japan genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 120 Japan genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 121 Japan genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 122 Japan genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 123 Japan genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 124 Japan genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 125 India genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 126 India genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 127 India genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 128 India genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 129 India genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 130 India genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 131 India genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 132 South Korea genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 133 South Korea genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 134 South Korea genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 135 South Korea genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 136 South Korea genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 137 South Korea genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 138 South Korea genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 139 Australia genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 140 Australia genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 141 Australia genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 142 Australia genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 143 Australia genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 144 Australia genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 145 Australia genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 146 Thailand genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 147 Thailand genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 148 Thailand genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 149 Thailand genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 150 Thailand genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 151 Thailand genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 152 Thailand genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 153 Latin America genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 154 Latin America genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 155 Latin America genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 156 Latin America genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 157 Latin America genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 158 Latin America genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 159 Latin America genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 160 Latin America genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 161 Brazil genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 162 Brazil genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 163 Brazil genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 164 Brazil genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 165 Brazil genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 166 Brazil genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 167 Brazil genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 168 Argentina genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 169 Argentina genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 170 Argentina genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 171 Argentina genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 172 Argentina genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 173 Argentina genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 174 Argentina genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 175 MEA genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 176 MEA genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 177 MEA genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 178 MEA genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 179 MEA genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 180 MEA genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 181 MEA genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 182 MEA genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 183 South Africa genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 184 South Africa genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 185 South Africa genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 186 South Africa genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 187 South Africa genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 188 South Africa genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 189 South Africa genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 190 Saudi Arabia genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 191 Saudi Arabia genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 192 Saudi Arabia genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 193 Saudi Arabia genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 194 Saudi Arabia genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 195 Saudi Arabia genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 196 Saudi Arabia genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 197 UAE genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 198 UAE genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 199 UAE genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 200 UAE genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 201 UAE genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 202 UAE genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 203 UAE genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 204 Kuwait genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 205 Kuwait genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 206 Kuwait genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 207 Kuwait genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 208 Kuwait genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 209 Kuwait genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 210 Kuwait genome editing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Genome editing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Segment snapshot - 2
  • Fig. 15 Segment snapshot - 3
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Life science tools market value, 2025 (USD billion)
  • Fig. 18 Market trends & outlook
  • Fig. 19 PESTEL analysis
  • Fig. 20 Porter's five forces analysis
  • Fig. 21 Genome editing market: Technology outlook key takeaways
  • Fig. 22 Genome editing market: Technology movement analysis
  • Fig. 23 CRISPR/Cas9 market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 TALENs/MegaTALs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 ZFN market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Meganucleases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Genome editing market: Delivery method outlook key takeaways
  • Fig. 29 Genome editing market: Delivery method movement analysis
  • Fig. 30 Ex vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 In vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Genome editing market: Application outlook key takeaways
  • Fig. 33 Genome editing market: Application movement analysis
  • Fig. 34 Genetic engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Cell line engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Animal genetic engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Plant genetic engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Clinical applications market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Diagnostics development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Therapy development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Genome editing market: Mode outlook key takeaways
  • Fig. 43 Genome editing market: Mode movement analysis
  • Fig. 44 Contract market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 In-house market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Genome editing market: End Use outlook key takeaways
  • Fig. 47 Genome editing market: End Use movement analysis
  • Fig. 48 Biotechnology and pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Academic and government research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)